Advanced and innovative
therapeutics within everyone’s reach, Celltrion Healthcare
In a hectic world many people get
lost in their busy lives often overlooking the smaller but important things.
They can lose sight of others,
those in need of our help.
Celltrion Healthcare started with a
belief that the world could be a better place if people showed more warmth and
offered a helping hand to those in need.
At Celltrion Healthcare, we
appreciate and never lose sight of the people around us.
We are committed to putting
patients first and believe that everyone deserves access to the treatments they
By specializing in marketing and
distribution of pharmaceutical products, Celltrion Healthcare has not only
conducted medical and marketing activities to educate and deliver accurate
information to healthcare professionals and patients, but have also thoroughly
managed the distribution process to maintain the best quality from dispatch of
medicinal products to administration on patients. Moreover, Celltrion
Healthcare operates a rigorous pharmacovigilance system because safety of
patients is the number one priority for us.
Biological agents account for a
very large portion of approximately 20% of the total pharmaceutical market and
80% of the top 10 pharmaceutical products. Biologics are expected to continue
to lead the growth of the global pharmaceutical market.
With this prospect, the future of
Celltrion Healthcare is even brighter than ever.
Globally, Celltrion Healthcare has
established a vast distribution network of partners and experts in more than
120 countries who have in-depth knowledge and experience in their local
Celltrion Healthcare establishes
global marketing strategies for Remsima, the world’s first monoclonal antibody
biosimilar, Truxima, and Herzuma, and executes marketing activities that are
optimized to each country with our global partners.
The attention that started as
simple curiosity on the world’s first monoclonal antibody biosimilar developer
has now changed to a stature standing side by side with leaders of the global
pharmaceutical industry, and Celltrion Healthcare attracts attention from the
medical community around the world whenever new clinical results are released.
Celltrion Healthcare’s medical and
marketing activities are not just restricted to physicians.
Celltrion Healthcare not only
educates pharmacists, nurses, and patient advocacy groups, but has also
persuaded government and insurance bodies to change policies in favor of
biosimilars by proving that patient accessibility can be improved with the
financial advantages of biosimilars. The NOR-SWITCH study voluntarily conducted
by the Norwegian government is a prime example.
Celltrion Healthcare began with
biosimilars and is becoming a global marketing and distribution specialist by
strengthening its medical and marketing capabilities.
Celltrion Healthcare is strengthening
its portfolio not only on new biosimilars, but also on chemical and new
antibody drugs that surpass biobetters, and will expand its business area
through mergers, acquisitions, and joint ventures.
At Celltrion Healthcare we are
heading a new era in biologic therapy. We are committed to delivering
affordable high quality advanced therapeutics to patients and those who care
Celltrion Healthcare will evolve
endlessly to ensure that necessary treatments will be available to all